Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial
Titel:
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial
Auteur:
Naimi, Rahim M Hvistendahl, Mark Enevoldsen, Lotte H Madsen, Jan L Fuglsang, Stefan Poulsen, Steen S Kissow, Hannelouise Pedersen, Jens Nerup, Nikolaj Ambrus, Rikard Achiam, Michael P Svendsen, Lars B Holst, Jens J Hartmann, Bolette Hansen, Svend H Dragsted, Lars O Steensberg, Adam Mouritzen, Ulrik Hansen, Mark B Jeppesen, Palle B